Publications
- Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story2019 | Third Faculty of Medicine
- Brentuximab vedotin treatment in clinical practice2018 | Third Faculty of Medicine
- PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group2017 | Third Faculty of Medicine
- Léčba relapsu Hodgkinova lymfomu po autologní transplantaci monoterapií brentuximab vedotinem2017 | Third Faculty of Medicine
- Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group2016 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Brentuximab vedotin in the treatment of lymphomas - practical experience2015 | Third Faculty of Medicine
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced stage Hodgkin Lymphoma: results from the randomized international GHSG HD18 trial2023 | Third Faculty of Medicine
Loading network view...